SENS
Senseonics Holdings, Inc.
$5.03
-6.16%
2026-05-08
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Key Fundamentals
Forward P/E
-2.18
EPS (TTM)
$-1.66
ROE
-168.3%
Revenue Growth (YoY)
71.8%
Profit Margin
-196.0%
Debt/Equity
67.77
Price/Book
3.86
Beta
1.06
Market Cap
$298.3M
Avg Volume (10D)
1.5M
Recent Breakout Signals
No recent breakout signals detected for SENS.
Recent Price Range (60 Days)
60D High
$8.57
60D Low
$4.79
Avg Volume
661K
Latest Close
$5.03
Get breakout alerts for SENS
Sign up for Breakout Scanner to receive daily notifications when SENS triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Senseonics Holdings, Inc. (SENS) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors SENS daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. SENS operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.